1. Home
  2. EVOK vs MITQ Comparison

EVOK vs MITQ Comparison

Compare EVOK & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • MITQ
  • Stock Information
  • Founded
  • EVOK 2007
  • MITQ N/A
  • Country
  • EVOK United States
  • MITQ United States
  • Employees
  • EVOK N/A
  • MITQ N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • EVOK Health Care
  • MITQ Telecommunications
  • Exchange
  • EVOK Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • EVOK 4.2M
  • MITQ 5.5M
  • IPO Year
  • EVOK 2013
  • MITQ 2021
  • Fundamental
  • Price
  • EVOK $2.70
  • MITQ $0.63
  • Analyst Decision
  • EVOK
  • MITQ
  • Analyst Count
  • EVOK 0
  • MITQ 0
  • Target Price
  • EVOK N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • EVOK 19.3K
  • MITQ 9.8M
  • Earning Date
  • EVOK 08-12-2025
  • MITQ 05-15-2025
  • Dividend Yield
  • EVOK N/A
  • MITQ N/A
  • EPS Growth
  • EVOK N/A
  • MITQ N/A
  • EPS
  • EVOK N/A
  • MITQ N/A
  • Revenue
  • EVOK $11,594,083.00
  • MITQ $18,613,000.00
  • Revenue This Year
  • EVOK $57.82
  • MITQ N/A
  • Revenue Next Year
  • EVOK $59.12
  • MITQ N/A
  • P/E Ratio
  • EVOK N/A
  • MITQ N/A
  • Revenue Growth
  • EVOK 89.89
  • MITQ N/A
  • 52 Week Low
  • EVOK $1.94
  • MITQ $0.50
  • 52 Week High
  • EVOK $12.32
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 43.42
  • MITQ 54.96
  • Support Level
  • EVOK $2.50
  • MITQ $0.62
  • Resistance Level
  • EVOK $2.84
  • MITQ $0.71
  • Average True Range (ATR)
  • EVOK 0.20
  • MITQ 0.07
  • MACD
  • EVOK -0.01
  • MITQ 0.00
  • Stochastic Oscillator
  • EVOK 47.45
  • MITQ 21.01

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: